All Entities (500)
Every published entity page, grouped by category.
Biological Process (19)
- (chemo)radiotherapy
- anti-inflammatory cytokines
- autophagy
- blood–brain barrier
- C-C motif chemokine ligand 2
- cancer immunotherapy
- cellular senescence
- cuproptosis
- cytokine
- EGFR/SRC-mediated EMT
- exercise
- ferroptosis
- human gut flora
- insulin resistance
- mitophagy
- oxidative stress
- photochemotherapy
- proinflammatory cytokine
- tumor microenvironment
Cellular Component (15)
Chemical (54)
- (E)-chlorogenic acid
- 17β-estradiol
- adenosine triphosphate
- all-trans retinoic acid
- amino acid
- apigenin
- berberine
- bisphenol A
- calcium
- camptothecin
- cannabidiol
- chitosan
- chrysin
- colloidal Au and Ag nanoparticles
- copper
- copper(2+)
- curcumin
- dapagliflozin
- dioxygen
- DL-methionine
- dopamine
- epigallocatechin gallate
- ethanol
- ferulic acid
- gallic acid
- glutathione
- honokiol
- hyaluronic acid
- hydrogen peroxide
- hydrogen sulfide
- indocyanine green
- Intracellular ROS
- kaempferol
- L-ascorbate
- L-glutamine
- luteolin
- manganese
- messenger RNA
- naringenin
- pectin
- prostaglandin E2
- quercetin
- reactive oxygen species
- resveratrol
- rosmarinic acid
- salvianolic acid B
- selenium nanoparticles
- silver
- taurine
- testosterone
- ubidecarenone
- uric acid
- zinc
- β-glucose
Clinical Metric (15)
- baseline estimated glomerular filtration rate (eGFR)
- body mass index
- Cancers
- cell-free tumour DNA
- D-dimer
- glomerular filtration rate
- hemoglobin A1c
- L-lactate dehydrogenase
- LDL cholesterol
- major adverse cardiovascular events
- overall survival
- progression-free survival
- salivary cortisol
- serum eGFR
- Serum glial fibrillary acidic protein
Disease (27)
- Age-related osteogenic failure
- Alzheimer's disease
- anxiety
- anxiety disorders
- breast cancer
- cardiovascular disease
- COVID-19
- diabetes
- diabetic retinopathy
- glioma
- heart failure
- hepatitis B
- hepatocellular carcinoma
- HIV infection
- hyperinsulinemic T2D patients
- lung cancer
- Metabolic dysfunction associated steatohepatitis
- metabolic dysfunction–associated steatotic liver disease
- mild cognitive impairment
- obesity
- ovarian cancer
- overt diabetes
- Parkinson's disease
- respiratory syncytial virus
- triple-negative breast cancer
- tumor
- type 2 diabetes
Gene (22)
- 5-gene signature (ANKRD29/CACNA2D2/DSP/HSD17B6/SPP1)
- BRAF gene
- BRAF V600E
- BRCA1
- BRCA2 DNA repair associated
- CD274
- cystic fibrosis transmembrane conductance regulator
- ESR1
- Forkhead box P3
- GSK3B
- heme oxygenase 1
- HER2 exon 20 insertion
- KRAS
- KRAS G12C
- KRAS G12D
- MIR21
- NAMPT
- PIK3CA
- platelet-derived growth factor receptor alpha
- TGFB1
- TP53
- Triggering receptor expressed on myeloid cells 2
Organism (16)
- Acinetobacter baumannii
- C. albicans ATCC 10231
- Candida albicans
- Escherichia coli
- Helicobacter pylori
- HIV
- HIV type 1
- human papilloma virus
- influenza A virus
- Klebsiella pneumoniae
- KrasLSL-G12D; Tp53fl/fl mice
- methicillin-resistant Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- SARS-CoV-2
- Staphylococcus aureus
Other (8)
Pathway (25)
- AMPK/mTOR
- CD44/JAK2/STAT3 signaling pathway
- cGAS-STING pathway
- cGAS-STING/NF-κB signaling pathway
- E2F2/PI3K/AKT signaling pathway
- FGF2-PI3K-Akt1 signaling
- fibrinogen complex
- JAK2/STAT3 signaling pathway
- MAPK signaling pathway
- Mitochondrial respiratory chain complex I
- mTORC1/2
- NF-κB
- Nrf-2-SLC7A11-GSH pathway
- Nrf2/GPx4 axis
- p53/cGAS/STING pathway
- PD-1/PD-L1
- PI3K/Akt signaling pathway
- PI3K/AKT/HIF-1α
- PI3K/AKT/mTOR pathway
- renin–angiotensin system
- SIRT1/HIF-1α pathway
- SIRT6/NRF2/GPX4 signaling pathway
- SLC7A11/GPX4 pathway
- Tlr2/Tlr4 signaling pathway
- Wnt/β-catenin pathway
Protein (150)
- Acetylcholinesterase (AChE)
- Acid α-glucosidase (AAG)
- Acyl-CoA synthetase long-chain family member 4 (ACSL4)
- Adiponectin (APN)
- Alpha-fetoprotein (AFP)
- AMP-activated protein kinase alpha 1 (AMPKα1)
- Amylase alpha 1C (AMY1C)
- Amyloid beta (Aβ)
- Anaplastic Lymphoma Kinase (ALK)
- Androgen receptor (AR)
- Angiotensin-converting enzyme 2 (ACE2)
- Apolipoprotein E4 (APOE4)
- Aurora kinase A (AURKA)
- B cell maturation antigen (BCMA)
- B7 homolog 3 (B7-H3)
- BCL2 apoptosis regulator
- Beta-secretase 1 (BACE1)
- Brain-derived neurotrophic factor (BDNF)
- Bromodomain-containing protein 4 (BRD4)
- Bruton tyrosine kinase (BTK)
- Butyrylcholinesterase (BCHE)
- C-reactive protein (CRP)
- C-X-C motif chemokine ligand 8 (CXCL8)
- C-X-C motif chemokine receptor 4
- Cadherin 1 (CDH1)
- Carbonic anhydrase IX (CA IX)
- Carcinoembryonic antigen (CEA)
- Cardiac troponin I (TNNI3)
- Caspase-1 (CASP1)
- Caspase-3 (CASP3)
- Cathepsin B (CTSB)
- CD274 molecule
- CD3+
- CD44
- Cluster of Differentiation 19 (CD19)
- Cluster of Differentiation 28 (CD28)
- Cluster of Differentiation 47 (CD47)
- Cyclin-dependent kinase 1 (CDK1)
- Cyclin-dependent kinase 2 (CDK2)
- Cyclin-dependent kinase 4 (CDK4)
- Cyclooxygenase 2 (COX-2)
- Cytochrome P450 (CYP)
- Cytochrome P450 3A4 (CYP3A4)
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
- Density-regulated re-initiation and release factor (DENR)
- Dipeptidyl peptidase 4 (DPP-4)
- DNA topoisomerase I (TOP1)
- Enhancer of Zeste Homolog 2 (EZH2)
- epidermal growth factor receptor
- Epidermal Growth Factor Receptor (EGFR)
- Epithelial Cell Adhesion Molecule (EpCAM)
- Estrogen Receptor Alpha (ERα)
- Fatty acid synthase (FASN)
- FGF21
- Fibroblast Activation Protein alpha (FAP)
- Fms-like tyrosine kinase 3 (FLT3)
- Focal adhesion kinase (FAK)
- Forkhead box O3 (FOXO3)
- Galectin-3 (LGALS3)
- Gasdermin D (GSDMD)
- Gasdermin E (GSDME)
- Glucagon-like peptide-1 (GLP-1)
- Glucagon-like peptide-1 receptor (GLP-1R)
- Glutamate carboxypeptidase II (GCPII)
- Glutathione peroxidase 4
- Glutathione Peroxidase 4 (GPX4)
- Glypican-3 (GPC3)
- growth factors TGF-β1 and VEGF
- Growth hormone (GH)
- Heat shock protein 90-alpha (Hsp90α)
- hemagglutinin
- Hepatocyte Nuclear Factor 1 Alpha (HNF1A)
- High mobility group box 1 (HMGB1)
- Histone Deacetylase 1 (HDAC1)
- Histone deacetylase 6 (HDAC6)
- Human epidermal growth factor receptor 2 (HER2)
- hypoxia inducible factor 1 subunit alpha
- Indoleamine 2,3-dioxygenase 1 (IDO1)
- insulin
- Insulin-like growth factor 1 (IGF-1)
- interferon
- interferon gamma (IFNG)
- Interferon regulatory factor 1 (IRF1)
- Interleukin 13 (IL13)
- Interleukin 17A (IL-17A)
- Interleukin 18 (IL-18)
- Interleukin-12 (IL-12)
- Interleukin-15 (IL-15)
- interleukin-17 family
- Interleukin-1β (IL-1β)
- Interleukin-6 (IL-6)
- JAK2
- Kelch-like ECH-associated protein 1 (KEAP1)
- Leptin (LEP)
- Lipocalin 2 (LCN2)
- Lysosomal-associated membrane protein 3 (LAMP-3)
- Matrix metalloproteinase-2 (MMP-2)
- Matrix Metalloproteinase-9 (MMP-9)
- Mechanistic target of rapamycin (mTOR)
- met
- Mitogen-Activated Protein Kinase 1 (MAPK1)
- MKI67
- Monoamine oxidase B (MAO-B)
- Mouse Double Minute 2 (MDM2)
- MYC proto-oncogene (MYC)
- Neurofilament Light Chain (NF-L)
- NLRP3 inflammasome
- non-structural protein 5 [SARS-CoV-2]
- Notch homolog 1 (NOTCH1)
- Nuclear factor erythroid 2-related factor 2 (NRF2)
- Nuclear receptor subfamily 1 group H member 4 (NR1H4)
- nuclear β-catenin positivity
- P-glycoprotein (P-gp)
- p53
- Peroxisome proliferator-activated receptor alpha (PPARα)
- Phosphatase and Tensin Homolog (PTEN)
- Phosphatidylinositol 3-kinase (PI3K)
- Poly(ADP-ribose) polymerase 1 (PARP1)
- Programmed cell death 1 (PD-1)
- Proprotein convertase subtilisin/kexin type 9 (PCSK9)
- Protein kinase B (PKB)
- Protein tyrosine phosphatase non-receptor type 1 (PTPN1)
- Protein tyrosine phosphatase non-receptor type 11 (PTPN11)
- Secreted phosphoprotein 1 (SPP1)
- senescence markers (p16 and p21)
- Signal Regulatory Protein Alpha (SIRPA)
- Signal Transducer and Activator of Transcription 3 (STAT3)
- Sirtuin 1 (SIRT1)
- Sodium-glucose cotransporter 2 (SGLT2)
- soluble programmed death-ligand 1 (sPD-L1)
- SOS Ras/Rac guanine nucleotide exchange factor 1 (SOS1)
- Stimulator of Interferon Genes (STING)
- Superoxide Dismutase (SOD)
- T cell immunoreceptor with Ig and ITIM domains (TIGIT)
- Th2 cytokines
- TNF receptor superfamily member 5 (TNFRSF5)
- TNF receptor superfamily member 9 (TNFRSF9)
- Toll-like receptor 4 (TLR4)
- Toll-like receptor 7/8
- Transforming growth factor beta (TGF-β)
- Tumor necrosis factor-α (TNF-α)
- Tumor-associated calcium signal transducer 2 (TACSTD2)
- TYK2-JAK1
- Tyrosinase (TYR)
- Vascular Endothelial Growth Factor A (VEGFA)
- Vascular endothelial growth factor receptor 2 (VEGFR2)
- Vimentin (VIM)
- Yes-associated protein 1 (YAP1)
- α-synuclein (SNCA)
- β-tubulin (TUBB)
Technology (11)
Therapy (138)
- abemaciclib
- acarbose
- adalimumab
- alectinib
- amoxicillin
- amphotericin B
- anti-PD-1 therapy
- anti-PD-L1
- antibody-drug conjugate
- apixaban
- aspirin
- atezolizumab
- Atorvastatin
- azithromycin
- belimumab
- bevacizumab
- bortezomib
- cabozantinib
- Caelyx
- calcineurin inhibitor
- capecitabine
- CAR-T cells
- carbamazepine
- carboplatin
- catequentinib
- ceftazidime-avibactam
- celastrol
- celecoxib
- cemiplimab
- cetuximab
- checkpoint inhibitor
- ciprofloxacin
- cisplatin
- cisplatin/fluorouracil
- clopidogrel
- COVID-19 vaccine
- cyclophosphamide
- dasatinib
- dexamethasone
- dexmedetomidine
- Diclofenac
- dipeptidyl peptidase-4 inhibitors
- docetaxel
- dolutegravir
- donepezil
- doxorubicin
- doxycycline
- dual immune checkpoint blockade
- dupilumab
- durvalumab
- electroacupuncture
- empagliflozin
- enfortumab vedotin
- enzalutamide
- erlotinib
- everolimus
- finerenone
- fluorouracil
- FOLFOX
- gefitinib
- gemcitabine
- GLP-1 medications
- glucagon-like peptide 1 receptor agonist
- glucagon-like peptide-1 agonist
- glucocorticoid
- HPV vaccination
- HPV vaccine
- ibrutinib
- ibuprofen
- immunization
- immunotherapy
- infliximab
- influenza vaccine
- Insulin Therapy
- intravitreal rituximab
- ipilimumab
- irinotecan hydrochloride
- Janus kinase inhibitors
- lenalidomide
- lenvatinib
- levodopa
- liraglutide
- melatonin
- mesalazine
- metformin
- methotrexate
- neoadjuvant or adjuvant chemotherapy
- nirmatrelvir/ritonavir
- nirsevimab
- nivolumab
- non-benzodiazepine receptor agonists
- ocrelizumab
- olaparib
- osimertinib
- oxaliplatin
- paclitaxel
- palbociclib
- PARP inhibitor
- PD-1/PD-L1 blockade
- pembrolizumab
- peptide
- photobiomodulation
- photothermal therapy
- placebo capsules
- platelet-rich plasma
- quadrivalent HPV vaccination
- quercetin hydrogel
- radiation therapy
- Ranibizumab
- rituximab
- rivaroxaban
- rutin
- ruxolitinib
- semaglutide
- SGLT2 inhibitor dapagliflozin
- sirolimus
- sodium glucose cotransporter-2 (SGLT2) inhibitors
- Sodium-glucose co-transporter 2 inhibitors
- sorafenib
- statin
- tamoxifen
- taxane
- temozolomide
- tirzepatide
- tislelizumab
- tocilizumab
- tofacitinib
- Topoisomerase I inhibitor SN-38
- trastuzumab
- Trastuzumab Rezetecan
- tyrosine-kinase inhibitor
- upadacitinib
- vancomycin
- VEGFR tyrosine kinase inhibitor
- venetoclax
- vitamin D
- zimberelimab
- αPD-L1